Institute for Clinical and Economic Review Appoints Dr. Pamela Bradt as Chief Scientific Officer

ICER

2 April 2019 - The Institute for Clinical and Economic Review has announced the appointment of Pamela Bradt as the organization's Chief Scientific Officer. 

Dr. Bradt brings proven experience as a physician leader and researcher across industry and academic settings. As ICER's new CSO, Dr. Bradt is responsible for leading the organization's research enterprise, including systematic evidence reviews and health economic modeling. 

As a member of ICER's Senior Management Team, Dr. Bradt will also help evolve ICER's methods of value assessment and expand the application of our work.

Read ICER announcement

Michael Wonder

Posted by:

Michael Wonder